SCHEMBL13601729

SCHEMBL13601729

CN(C)CCCOC(=O)C(=O)N1CCN(C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HTR1A P08908 1/20 0.38
GAA P10253 2/20 0.37
CYP1A2 P05177 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
TSHR P16473 1/20 0.35
CACNA1B Q00975 2/20 0.34
NPC1 O15118 1/20 0.34
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601727 0.90 CHRM2 (0.43) MAPTALDH1A1HTR1AGAACYP1A2
SCHEMBL12881477 0.88 GNAI3 (0.42) MAPTALDH1A1GAAL3MBTL1TSHR
SCHEMBL12881484 0.88 ACHE (0.41) MAPTALDH1A1GAATDP1L3MBTL1
SCHEMBL12881494 0.87 L3MBTL1 (0.42) MAPTALDH1A1GAATDP1L3MBTL1
SCHEMBL13601690 0.83 MAPT (0.44) MAPTALDH1A1GAAL3MBTL1NPC1
SCHEMBL13601726 0.82 SMN1; SMN2 (0.45) MAPTALDH1A1HTR1AGAACYP1A2
SCHEMBL13601725 0.79 TSHR (0.49) MAPTALDH1A1HTR1AGAATSHR
SCHEMBL12881480 0.79 MAPT (0.43) MAPTALDH1A1GAAL3MBTL1CHRM2
SCHEMBL12881488 0.79 ACHE (0.43) MAPTGAATDP1L3MBTL1CHRM2
SCHEMBL13601724 0.78 MAPT (0.44) MAPTALDH1A1HTR1AGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed